Alzheimer's Disease Genetics and ABCA7 Splicing

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• ABCA7 gene polymorphisms are linked to Alzheimer's disease (AD) risk.
• A specific rare polymorphism, rs200538373, is associated with increased AD risk (odds ratio ~1.9).
• This polymorphism is suspected to affect ABCA7 splicing, particularly exon 41.

Purpose of the Study:

• To investigate the functional impact of the rs200538373 polymorphism on ABCA7 exon 41 splicing.
• To determine if this polymorphism alters ABCA7 mRNA levels in human brain tissue.

Main Methods:

• Minigene splicing assays were performed to assess the in vitro splicing activity of ABCA7.
• Quantitative PCR (qPCR) was used to analyze ABCA7 splicing and mRNA levels in human brain RNA samples.
• Analysis included RNA from a carrier of the rs200538373 minor C allele.

Main Results:

• Aberrant splicing of ABCA7 exon 41 was observed in the brain of an rs200538373 C allele carrier.
• In vitro minigene studies confirmed rs200538373 as a functional variant influencing splicing.
• Despite altered splicing, qPCR analysis revealed relatively normal overall ABCA7 mRNA levels in the carrier, contradicting predictions of nonsense-mediated decay.

Conclusions:

• The rs200538373 polymorphism is a functional genetic variant that specifically disrupts ABCA7 exon 41 splicing.
• The observed splicing alteration does not lead to a significant reduction in total ABCA7 mRNA abundance.
• This finding provides mechanistic insight into how ABCA7 genetic variations contribute to Alzheimer's disease pathogenesis.